ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.

@article{Gobbi2005ABVDVM,
  title={ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.},
  author={Paolo G. Gobbi and Alessandro Levis and Teodoro Chisesi and Chiara Broglia and Umberto Vitolo and Caterina Stelitano and Vincenzo Pavone and Luigi Cavanna and Gino Santini and Francesco Merli and Marina Liberati and Luca Baldini and Giorgio Lambertenghi Deliliers and Emanuele Angelucci and Roberto Bordonaro and Massimo Federico},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2005},
  volume={23 36},
  pages={
          9198-207
        }
}
PURPOSE In this multicenter, prospective, randomized clinical trial on advanced Hodgkin's lymphoma (HL), the efficacy and toxicity of two chemotherapy regimens, doxorubicin, vinblastine, mechlorethamine, vincristine, bleomycin, etoposide, and prednisone (Stanford V) and mechlorethamine, vincristine, procarbazine, prednisone, epidoxirubicin, bleomycin, vinblastine, lomustine, doxorubicin, and vindesine (MOPPEBVCAD), were compared with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 71 CITATIONS, ESTIMATED 41% COVERAGE

Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma

  • Advances in hematology
  • 2011
VIEW 7 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma

  • Advances in hematology
  • 2011
VIEW 4 EXCERPTS
CITES RESULTS
HIGHLY INFLUENCED

Standard therapy of advanced Hodgkin lymphoma.

  • Hematology. American Society of Hematology. Education Program
  • 2009
VIEW 5 EXCERPTS
CITES METHODS
HIGHLY INFLUENCED

XVII. Treatment of advanced-stage Hodgkin lymphoma.

  • Hematological oncology
  • 2015
VIEW 3 EXCERPTS
CITES RESULTS
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2006
2019

CITATION STATISTICS

  • 7 Highly Influenced Citations

References

Publications referenced by this paper.
SHOWING 1-10 OF 34 REFERENCES

Advanced Hodgkin's disease: ABVD is better, yet is not good enough!

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2003
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 1989
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2003
VIEW 1 EXCERPT

Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2002
VIEW 2 EXCERPTS